ContraFect Corporation
CFRXQ · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $4 | $5 | $5 | $4 |
| G&A Expenses | $0 | $0 | $0 | $2 |
| SG&A Expenses | $3 | $3 | $4 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | -$0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $7 | $8 | $9 | $7 |
| Operating Income | -$7 | -$8 | -$9 | -$7 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1 | $0 | $7 | -$3 |
| Pre-Tax Income | -$5 | -$8 | -$1 | -$10 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | -$8 | -$1 | -$10 |
| % Margin | – | – | – | – |
| EPS | -0.5 | -1.94 | -0.69 | -16.14 |
| % Growth | 74.2% | -181.2% | 95.7% | – |
| EPS Diluted | -0.5 | -1.94 | -0.69 | -16.14 |
| Weighted Avg Shares Out | 11 | 4 | 2 | 1 |
| Weighted Avg Shares Out Dil | 11 | 4 | 2 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$7 | -$8 | -$9 | -$7 |
| % Margin | – | – | – | – |